SEC Form 4 · accession 0001209191-16-140050
Foundation Medicine, Inc. · FMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Daly
Officer — Chief Commercial Officer
Period of report
Sep 1, 2016
Accepted (ET)
Sep 6, 2016 · 4:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001488613
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Sep 1, 2016 | S | 551 | $20.48 | D | 108,899 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on August 31, 2016. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person.
- F2The reporting person previously reported the restricted stock units granted to the reporting person on December 5, 2014 in Table I of the Form 4 filed on December 9, 2014. As such, no adjustment to the reporting persons beneficial interest needs to be made to reflect the vesting event related to this securities sale.